Log In
Print this Print this

Binosto, Steovess, alendronate (EX101)

  Manage Alerts
Collapse Summary General Information
Company EffRx Pharmaceuticals S.A.
DescriptionAlendronate effervescent
Molecular Target Unknown
Mechanism of ActionUnknown
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationOsteoporosis
Indication DetailsTreat osteoporosis
Regulatory Designation
PartnerAbiogen Pharma S.p.A.;
Ahn-Gook Pharmaceutical Co. Ltd.;
Hikma Pharmaceuticals plc;
Laboratorios Atral S.A.;
Merck & Co. Inc.;
Midatech Pharma plc;
Mission Pharmacal Co.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today